These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 22580535)
1. Effect of ESR1 and ESR2 gene polymorphisms on rheumatoid arthritis treatment with methotrexate. Pawlik A; Dziedziejko V; Kurzawski M; Safranow K; Kotrych D; Bohatyrewicz A Pharmacol Rep; 2012; 64(1):185-90. PubMed ID: 22580535 [TBL] [Abstract][Full Text] [Related]
2. The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide. Dziedziejko V; Kurzawski M; Safranow K; Chlubek D; Pawlik A Pharmacogenomics; 2011 Jan; 12(1):41-7. PubMed ID: 21174621 [TBL] [Abstract][Full Text] [Related]
3. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate. Kotrych D; Dziedziejko V; Safranow K; Pawlik A Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3037-40. PubMed ID: 26367725 [TBL] [Abstract][Full Text] [Related]
4. Effect of allograft inflammatory factor-1 gene polymorphisms on rheumatoid arthritis treatment with methotrexate. Pawlik A; Herczynska MM; Dziedziejko V; Malinowski D; Kurzawski M; Drozdzik M; Gawronska-Szklarz B Postepy Hig Med Dosw (Online); 2013 Jul; 67():637-42. PubMed ID: 24018427 [TBL] [Abstract][Full Text] [Related]
5. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis. Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981 [TBL] [Abstract][Full Text] [Related]
6. Oestrogen receptor polymorphisms in female patients with rheumatoid arthritis. Dziedziejko V; Kurzawski M; Safranow K; Drozdzik M; Chlubek D; Pawlik A Scand J Rheumatol; 2011; 40(5):329-33. PubMed ID: 21762042 [TBL] [Abstract][Full Text] [Related]
7. Polymorphism in Organic Anion-Transporting Polypeptide Gene Related to Methotrexate Response in Rheumatoid Arthritis Treatment. Takahashi K; Nakamura H; Watanabe A; Majima T; Koiwa M; Kamada T; Takai S J Nippon Med Sch; 2019; 86(3):149-158. PubMed ID: 31292326 [TBL] [Abstract][Full Text] [Related]
8. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients. Singh A; Gangadharan H; Gupta V; Patro PS; Misra R; Aggarwal A Int J Rheum Dis; 2021 May; 24(5):654-662. PubMed ID: 33780152 [TBL] [Abstract][Full Text] [Related]
9. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis. Muralidharan N; Mariaselvam CM; Mithun CB; Negi VS Clin Rheumatol; 2016 Apr; 35(4):879-85. PubMed ID: 25771854 [TBL] [Abstract][Full Text] [Related]
10. The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs. Drozdzik M; Rudas T; Pawlik A; Kurzawski M; Czerny B; Gornik W; Herczynska M Eur J Clin Pharmacol; 2006 Nov; 62(11):933-7. PubMed ID: 16932953 [TBL] [Abstract][Full Text] [Related]
11. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients. Lima A; Seabra V; Bernardes M; Azevedo R; Sousa H; Medeiros R PLoS One; 2014; 9(10):e108165. PubMed ID: 25279663 [TBL] [Abstract][Full Text] [Related]
12. The association of bone mineral density with estrogen receptor gene polymorphisms. Greendale GA; Chu J; Ferrell R; Randolph JF; Johnston JM; Sowers MR Am J Med; 2006 Sep; 119(9 Suppl 1):S79-86. PubMed ID: 16949392 [TBL] [Abstract][Full Text] [Related]
13. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis. Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736 [TBL] [Abstract][Full Text] [Related]
14. Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study. Massart F; Marini F; Bianchi G; Minisola S; Luisetto G; Pirazzoli A; Salvi S; Micheli D; Masi L; Brandi ML Reprod Biol Endocrinol; 2009 Apr; 7():32. PubMed ID: 19386104 [TBL] [Abstract][Full Text] [Related]
15. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment. Marwa OS; Kalthoum T; Wajih K; Kamel H Immunol Lett; 2017 Mar; 183():24-36. PubMed ID: 28143790 [TBL] [Abstract][Full Text] [Related]
16. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway. Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125 [TBL] [Abstract][Full Text] [Related]
17. Factors Predicting the Therapeutic Response to Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Hospital-Based Cohort Study. Hakamata J; Kaneko Y; Shimizu M; Yamaoka K; Maruyama J; Takeuchi T; Mochizuki M; Hashiguchi M Biol Pharm Bull; 2018; 41(9):1414-1422. PubMed ID: 30175777 [TBL] [Abstract][Full Text] [Related]
18. No correlation between MTHFR c.677 C > T, MTHFR c.1298 A > C, and ABCB1 c.3435 C > T polymorphisms and methotrexate therapeutic outcome of rheumatoid arthritis in West Algerian population. Boughrara W; Benzaoui A; Aberkane M; Moghtit FZ; Dorgham S; Lardjam-Hetraf AS; Ouhaibi-Djellouli H; Teixeira EP; Boudjema A Inflamm Res; 2017 Jun; 66(6):505-513. PubMed ID: 28299396 [TBL] [Abstract][Full Text] [Related]
19. Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis. Muralidharan N; Misra DP; Jain VK; Negi VS Clin Rheumatol; 2017 Jun; 36(6):1253-1259. PubMed ID: 28349270 [TBL] [Abstract][Full Text] [Related]
20. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis. Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]